AlphaGrep UK’s Celestica CLS Stock Holding History

AlphaGrep UK’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-556	Closed	-$203K	–	781
2026 Q2	$203K	Sell	556 -689	-55%	-$259K	0.06%	680
2026 Q1	$351K	Buy	+1,245	New	+$361K	0.1%	435

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.4B AUM 32.2% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Whale Rock Capital Management Boston, Massachusetts $11.4B AUM 188.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.4B AUM 28.28% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

AlphaGrep UK's CLS Position: Q3 2026 in Review

AlphaGrep UK sold out of Celestica (CLS) in Q3 2026, closing a stake of 556 shares — an estimated $203K sold.

AlphaGrep UK first reported a position in CLS in Q1 2026 and held it in 2 quarters. The position peaked at $351K in Q1 2026. 759 funds tracked by Wall St. Rank hold CLS as of Q3 2026.

AlphaGrep UK reported no remaining Celestica position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 556 Celestica shares in Q3 2026, an estimated $203K.
AlphaGrep UK first reported a position in Celestica in Q1 2026 and held it in 2 quarters.
AlphaGrep UK's Celestica position peaked at $351K in Q1 2026.
759 funds tracked by Wall St. Rank held Celestica as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.